Multi-Scale Phase Velocity Resonator Calibration and Active Surgical Phase Inversion for Closed-Loop Speech Neuromodulation Across Pediatric and Adolescent Baselines
Developmental speech articulation disorders and pathological vocal acceleration states, designated as Super Electro Velocity (SEV) transitions, are modeled as high-frequency neurological overloads driven by uninhibited trans-endothelial voltage surges within Broca's Area. This paper establishes a quantitative biophysical framework that maps developmental maturation curves from healthy pediatric baselines to stabilized adolescent target zones using the Phase Velocity Resonator Law (\(v = D_{\text{mol}} \times f_{bs}\)). Healthy pediatric parameters are anchored at initial growth thresholds characterized by a structural diameter (\(D_{\text{mol}}\)) of 1 mm, an induced potential of 1 V, and a baseline frequency of 30 Hz, deriving a native pediatric elastic permeability constant of \(\Phi \approx 333.33 \text{ V}\cdot\text{s/m}\). Maturation into adolescence shifts the tissue matrix to an optimal operational baseline of 2 mm and 2 V at a high-Gamma frequency of 100 Hz (\(\Phi = 10 \text{ V}\cdot\text{s/m}\)). Conversely, abnormal macrovascular dilations (e.g., 5 mm) under SEV conditions cause volatile overloads up to 5 V. To resolve this speech bottleneck, we implement Equation III (Focused External Surgical Interference) to deliver an external multi-harmonic counter-wave calibrated with a strict \(180^{\circ }\) anti-phase delay window (\(\Delta t = 5\text{ ms}\)). This active intervention achieves complete destructive wave interference (\(I_{\text{surgery}} = 0\)), safely diluting volatile electronic clusters from an overload state of \(15,000\text{--}20,000\) active charges back to a stable homeostatic baseline of exactly \(10,000\) charges without tissue degradation.
Authors
- abdelhadi Abouelfida
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-30
- DOI
- https://doi.org/10.5281/zenodo.23816256
- Primary Topic
- Voice and Speech Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00